Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EVINACUMAB-DGNB for Type iia hyperlipidaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 50 adverse event reports in the FDA FAERS database where EVINACUMAB-DGNB was used for Type iia hyperlipidaemia.

Most Reported Side Effects for EVINACUMAB-DGNB

Side Effect Reports % Deaths Hosp.
Nausea 14 15.2% 0 1
Fatigue 12 13.0% 0 2
Pain 9 9.8% 0 1
Hepatic steatosis 7 7.6% 0 0
Diarrhoea 6 6.5% 0 0
Dizziness 6 6.5% 0 0
Drug ineffective 6 6.5% 0 1
International normalised ratio increased 6 6.5% 0 0
Product dose omission issue 6 6.5% 0 0
Death 5 5.4% 5 0
Headache 5 5.4% 0 0

Other Indications for EVINACUMAB-DGNB

Product used for unknown indication (33) Hypercholesterolaemia (8)

Other Drugs Used for Type iia hyperlipidaemia

EVOLOCUMAB (5,556) LOMITAPIDE (3,314) ALIROCUMAB (1,913) ATORVASTATIN (637) EZETIMIBE (562) ROSUVASTATIN (547) INCLISIRAN (313) SIMVASTATIN (294) PRAVASTATIN (152) JUXTAPID (145)

Related Pages

EVINACUMAB-DGNB Full Profile All Type iia hyperlipidaemia Drugs EVINACUMAB-DGNB Demographics EVINACUMAB-DGNB Timeline